Navigation Links
Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C
Date:11/5/2007

ed at least comparable efficacy and comparable safety vs. peginterferon alfa-2a (ITT analysis), with less impairment of quality of life on treatment and fewer lost days of work. The final Phase 2b results include the following SVR rates and other findings:

Albuferon 900-mcg Every Two Weeks (Albuferon 900 Q2w)

-- Based on an intention-to-treat (ITT) analysis, 58.5% of patients in the

Albuferon 900 Q2w treatment group achieved SVR, vs. 57.9% for

peginterferon alfa-2a administered every week.

-- In heavier patients (75 kg or heavier) who were treatment-adherent,

74.2% of those in the Albuferon 900 Q2w treatment group achieved SVR,

versus 53.3% for peginterferon alfa-2a.

-- Among all treatment-adherent patients in the Albuferon 900 Q2w

treatment group, 72.3% achieved SVR, versus 66.7% for peginterferon

alfa-2a.

-- Based on the SF-36 Health Survey, patients in the Albuferon 900 Q2w

treatment group reported less impairment of health-related quality of

life, compared with patients in the peginterferon alfa-2a treatment

group, as measured by both physical component and mental component SF-

36 summary measures at all time-points throughout the 48-week treatment

period.

-- Significantly fewer working patients in the Albuferon 900 Q2w treatment

group reported missing 7 days or more of work during the month prior to

their visits at Weeks 12 and 24, vs. the peginterferon alfa-2a group

(p<.05; Week 12: 4.2% for Albuferon 900 Q2w vs. 18.1% for

peginterferon alfa-2a; Week 24: 5.3% for Albuferon 900 Q2w, vs. 20.3%

for peginterferon alfa-2a).

-- The rate of discontinuations due to adverse events was 9.3% in the

Albuferon 900 Q2w treatment group, vs. 6.1% in the peginterferon alfa-

2a group. Adverse events observed were those typically expected with

interferon therapy. '/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...nstrates potent antiviral activity and favorable s...MBRIDGE, Mass., Sept. 4 /- ...iopharmaceutical company engaged,in the discovery ...n viral,and other infectious diseases, today annou...udy evaluating IDX899, a non-nucleoside reverse,tr...
(Date:9/4/2008)...s Remain on Schedule with Two Abstracts Accepted f...se in November 2008, BRIDGEWATER, N.J., Sept. 4 /...pecialty pharmaceutical company focused on the tre...day announced the appointment of,Peter L. Garrambo...er Garrambone,s career includes more than 50 pharm...
(Date:9/3/2008)...uestion Asked. Wrong Children Studied. Wrong,Concl...SNewswire/ -- A Centers for Disease,Control and Pr...s no link,between the MMR vaccine and autism. The ...does nothing to dispel the growing public concern ...l questions concerning design,and methodology., F...
(Date:9/3/2008)...ge of Rheumatology Research and Education Foundati... Advances in Detecting, Treati...wire/ -- For the first time during its,unprecedent...tis, the,American College of Rheumatology Research...tion acquired from research funded by the Within O...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Females avoid incest by causing male relatives to leave home 54 1Females avoid incest by causing male relatives to leave home 54 2Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia 51 1Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia 51 2First biomarker discovered that predicts prostate cancer outcome 48 1First biomarker discovered that predicts prostate cancer outcome 48 2First biomarker discovered that predicts prostate cancer outcome 48 3First biomarker discovered that predicts prostate cancer outcome 48 4Breast cancer prevention practices vary across Canada 45 1Breast cancer prevention practices vary across Canada 45 2
... Francophone du Myelome (IFM),Trial Presented Duri...ire-FirstCall/ --,Millennium Pharmaceuticals, Inc....e comparative Phase III clinical trial evaluating ...e myeloma (MM),patients. As induction therapy prio...based therapy produced a high complete remission,/...
...d Pivotal Phase 3 Trial CL-05, CHICAGO, July 02, 2...es Holdings, Inc. , today announced the confirmati... the first of two,pivotal Phase 3 clinical trials ... cethromycin, a novel once-a-day antibiotic, for,t.... The Company,also provided an update to the proje...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
... U.S prescription use released last week revealed ...tion// for Attention Deficiency Hyperactivity Diso...f a similar prescription themselves. In the year 2... children and their parents were studied by resear...
...tarted to dissuade and at times even forbid birthd...sity. // "They can bring carrots," said Laura Ott,...thday girl, Cassidy Stewart received a card, a sti...s from her classmates. Her school; Mission Viejo o...
...severe coronary artery disease live longer if they...nitial treatment // instead of artery-opening angi...University Medical Center analysis. Yet up to 40 ...ere coronary disease are treated first with angiop...
...a low-carb diet replacing starches and sugars with...hey may do something radically different. // A re...ests that the major change in eating patterns for ...been the addition of large amounts of vegetables a...
Other Medicine News:Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 2Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 3Health News:Low-Carb Dieters Eat More Vegetables 2
..., Available in even sizes 20-36F. Single use. A di...tient comfort. The Latex-Free Robertazzi is the id... the best solution for latex sensitivity. It is ec...latex-free product as your standard nasal airway c...
Soft red rubber. Adjustable flange. Pediatric sizes available.
Smooth flexible medical grade white low density polyethylene with reinforced block to prevent collapse.
Two-channel, Berman design. Semirigid, nontoxic polyethylene. Individually packaged, 48 per case. Latex Free.
Medicine Products: